Companies can choose between several alternative processes, depending on product types and the number of countries where they wish to sell them.
Parallel trade permit
A short application procedure of 90 days for companies wishing to make a biocidal product already authorised in one EU Member State available on the market in another Member State. In order to obtain this permit, the product to be made available on the market must be identical to a biocidal product already authorised in the Member State of introduction ("the reference product").
The BPR provides for a simpler and cheaper authorisation procedure for less harmful biocidal products. This procedure may be used for a biocidal product, if all the active substances contained in the product appear in Annex I and the product is effective and contains no substance of concern and no nanomaterials and if personal protective equipment is not required.
National authorisationIf the product is to be placed only on one single Member State market, authorisation from that country is sufficient.
There are two processes for mutual recognition: Mutual recognition in sequence and Mutual recognition in parallel.
Mutual recognition in sequenceIf a company wishes to place the product on the market in several countries, it can apply for mutual recognition for the product authorisation.
Mutual recognition in parallel
A company applies for national authorisation in one EU Member State and at the same time submits an application for mutual recognition to other EU Member States.
As a new alternative, companies may now apply for an EU authorisation of a biocidal product. An EU authorisation authorises the product in all EU Member States in one go.
Experimental testing of products
Products with new formulations and/or active substances, which is under development, can be tested experimentally with the approval from the Danish Environmental Protection Agency. This is also applicable for products, which is already approved, but new usages needs to be tested for other areas of used other than approved.
Authorisation under the old Danish authorisation scheme
During the transitional period where the EU is evaluating the active substances substances and products covered by the old Danish authorisation scheme must still be authorised under these rules.